Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays-Reference-Cited by-同舟云学术

Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays

Published:2016-06 Issue: Volume:125 Page:62-67
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Bian Sumin,Stappen Thomas Van,Baert Filip,Compernolle Griet,Brouwers Els,Tops Sophie,Vries Annick de,Rispens Theo,Lammertyn Jeroen,Vermeire Séverine,Gils Ann

Funder

KU Leuven

China Scholarship Council

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference27 articles.

1. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2012

2. Adalimumab for maintenance of clinical response and remission in patients with crohn’s disease: the CHARM trial;Colombel;Gastroenterology,2007

3. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness;Chen;Health Technol. Assess.,2006

4. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial;Gladman;Arthr. Rheumatol.,2007

5. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial;van der Heijde;Arthr. Rheum.,2006

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17

2. Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases;Biosensors and Bioelectronics;2022-07

3. Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridge;Biosensors and Bioelectronics;2022-06

4. Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice;Journal of Clinical Medicine;2022-05-26

5. Rapid biosensing SARS-CoV-2 antibodies in vaccinated healthy donors;Biosensors and Bioelectronics;2022-05